The correlates of neonatal complement component 3 and 4 protein concentrations with a focus on psychiatric and autoimmune disorders.
C3
C4
Mendelian randomization
autoimmune disorders
complement component
dried blood spots
genome-wide association study
phenome-wide association study
psychiatric disorders
schizophrenia
Journal
Cell genomics
ISSN: 2666-979X
Titre abrégé: Cell Genom
Pays: United States
ID NLM: 9918284260106676
Informations de publication
Date de publication:
13 Dec 2023
13 Dec 2023
Historique:
received:
06
06
2023
revised:
03
09
2023
accepted:
08
11
2023
medline:
20
12
2023
pubmed:
20
12
2023
entrez:
20
12
2023
Statut:
epublish
Résumé
Complement components have been linked to schizophrenia and autoimmune disorders. We examined the association between neonatal circulating C3 and C4 protein concentrations in 68,768 neonates and the risk of six mental disorders. We completed genome-wide association studies (GWASs) for C3 and C4 and applied the summary statistics in Mendelian randomization and phenome-wide association studies related to mental and autoimmune disorders. The GWASs for C3 and C4 protein concentrations identified 15 and 36 independent loci, respectively. We found no associations between neonatal C3 and C4 concentrations and mental disorders in the total sample (both sexes combined); however, post-hoc analyses found that a higher C3 concentration was associated with a reduced risk of schizophrenia in females. Mendelian randomization based on C4 summary statistics found an altered risk of five types of autoimmune disorders. Our study adds to our understanding of the associations between C3 and C4 concentrations and subsequent mental and autoimmune disorders.
Identifiants
pubmed: 38116117
doi: 10.1016/j.xgen.2023.100457
pii: S2666-979X(23)00301-4
pmc: PMC10726496
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
100457Informations de copyright
© 2023 The Author(s).
Déclaration de conflit d'intérêts
C.M.B. reports Pearson (author, royalty recipient) and Equip Health Inc. (Stakeholder Advisory Board). B.J.V. reports Allelica (Scientific Advisory Board).